Ticker Details
Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$6.09B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.58 | 2.94%
Avg Daily Range (30 D):	$3.37 | 2.92%
Avg Daily Range (90 D):	$2.58 | 2.33%

Institutional Daily Volume
Avg Daily Volume:	.15M
Avg Daily Volume (30 D):	.54M
Avg Daily Volume (90 D):	.55M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	45
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	987
Avg Institutional Trade:	$4.2M
Avg Institutional Trade (30 D):	$7.66M
Avg Institutional Trade (90 D):	$8.01M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$7.19M
Avg Closing Trade (30 D):	$14.33M
Avg Closing Trade (90 D):	$12.9M
Avg Closing Volume:	121.48K

News

Mar 27, 2026 @ 12:05 AM Why Celcuity Stock Popped Today Source: Eric Volkman

Mar 13, 2026 @ 2:28 PM Inside One Fund's $170 Million Bet on a Biotech St... Source: Jonathan Ponciano

Mar 9, 2026 @ 9:42 PM Celcuity Announces Publication of Results from PIK... Source: Celcuity Inc.

Feb 22, 2026 @ 7:05 PM Celcuity Stock Soars 700% in a Year as One Investo... Source: Jonathan Ponciano

Feb 13, 2026 @ 12:34 PM Soleus Adds a Significant Number of Celcuity Share... Source: Lawrence Rothman, Cfa

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.79	$-.98	$-3.79
Diluted EPS	$-3.79	$-.98	$-3.79
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-177.04M	$-50.97M	$-177.04M
Operating Income / Loss	$-172.19M	$-49.2M	$-172.19M
Cost of Revenue
Net Cash Flow	$143.19M	$91.45M	$143.19M
PE Ratio